Condition
HIV Lipodystrophy Syndrome
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
Termination Rate
50.0%
2 terminated out of 4 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
2Total
P 4 (2)
Trial Status
Completed2
Terminated2
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03226821Phase 4TerminatedPrimary
Body Composition and Adipose Tissue in HIV
NCT02530827Completed
Energy Expenditure of People Living With HIV/AIDS
NCT00069004Completed
A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
NCT00122655Phase 4Terminated
Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy
Showing all 4 trials